Abcuro, Inc., 2026-08-13
An SEC Form D private-offering notice from Newton, MA, a $176,522,953 filer-stated offering target in Biotech. Filed 2026-08-13. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage biotechnology company developing immunotherapies targeting cytotoxic T cells for autoimmune diseases and certain cancers.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Carnot Labs, Inc., 2026-08-13, $8.1M, Charlestown, MA
- iReprogram, Inc, 2026-08-13, $25M, Ann Arbor, MI
- HYKU BIOSCIENCES INC., 2026-08-13, $8.6M, Concord, MA
- Auron Therapeutics, Inc., 2026-08-13, $12M, Wellesley, MA
- Rapid Liquid Print Co., 2026-08-12, $2.2M, Charlestown, MA
- Trace Biosciences Inc., 2026-08-12, $16.2M, Beaverton, OR
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.